These studies underscore the importance of glucose transporters in lung cancer and suggest that incorporating the analysis of SGLT2 expression, along with other transporters like GLUT1, could refine diagnostic imaging techniques and offer new avenues for treatment. This evidence concerns the gene SLC5A2 and lung cancer.